Several data are in favour of the involvement of IL-1 in the pathophysiology of GCA, including in vitro data, mouse models, and studies on GCA patients, including the efficacy of anti-IL-1 treatment based on case reports [29, 30]. This evidence concerns the gene IL1B and temporal arteritis.